Created in 1931 (Germany), Angiolysin own 1125 sister brands and 17477 competing brands. The Angiolysin brand is owned by Pfizer Inc, a company listed in New York. Angiolysin belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(Angiolysin)
over 5 years*
USD 19.02